Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure

NCT: NCT05193084 · COMPLETED

NCT IDNCT05193084
StatusCOMPLETED
Start Date2022-03-01
Completion2023-06-13

Brief Summary

This study will aim to collect proof of concept data to inform the study design of a larger paired comparison study to establish key research questions about the Heartfelt device. The current study will be run with 2 parallel workstreams. Both are presented here: Data collected from Work Stream 1 (WS1) is expected to give an indication of the usefulness of the volumes measured by the Heartfelt device in optimising diuretic therapy for patients undergoing ambulatory-IV diuretic treatment, as well as looking at the usefulness of foot volume changes monitoring post IV Diuretic treatment. As these patients are often managed in a home / community setting, objective indicators to assess oedema during treatment are currently limited. Data collected from Work Stream 2 (WS2), patients recently discharged after a heart failure hospitalisation (HFH), is expected to determine if the Heartfelt device can be used to monitor heart failure stability and detect fluid overload in patients recently discharged from hospital after an episode of decompensated heart failure. The investigators may also be able to get an indication of the number of days prior to hospital admission during which the Heartfelt device can detect changes in foot volume. Both workstreams will provide qualitative feedback, from health care practitioners, patients and carers in both groups about their experience using the Heartfelt Device.

Frequently Asked Questions

What is Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure?

Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure is a clinical trial registered under NCT05193084. Current status: COMPLETED.

What is the status of NCT05193084?

The current status of NCT05193084 (Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure) is: COMPLETED.

When did Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure start?

Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure started on 2022-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.